Bharat Serums AND Vaccines Limited — Folic Exporter Profile
Indian Pharmaceutical Exporter · #9 for Folic · $1.3M export value · DGFT Verified
Bharat Serums AND Vaccines Limited is the #9 Indian exporter of Folic with $1.3M in export value and 78 verified shipments. Bharat Serums AND Vaccines Limited holds a 2.4% market share in Folic exports across 11 countries. The company exports 4 pharmaceutical products worth $40.1M across 3 therapeutic categories.
Bharat Serums AND Vaccines Limited — Folic Export Profile: Buyers & Destinations
Where Does Bharat Serums AND Vaccines Limited Export Folic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $491.1K | 15 | 41.3% |
| IRAQ | $369.6K | 8 | 31.1% |
| PHILIPPINES | $113.4K | 8 | 9.5% |
| ZIMBABWE | $66.0K | 7 | 5.5% |
| NIGERIA | $54.6K | 2 | 4.6% |
| FRANCE | $41.2K | 17 | 3.5% |
| RWANDA | $24.1K | 8 | 2.0% |
| CAMBODIA | $11.0K | 5 | 0.9% |
| NEPAL | $9.3K | 4 | 0.8% |
| BURUNDI | $6.4K | 2 | 0.5% |
Bharat Serums AND Vaccines Limited exports Folic to 11 countries. The largest destination is MALAYSIA accounting for 41.3% of Bharat Serums AND Vaccines Limited's Folic shipments, followed by IRAQ (31.1%) and PHILIPPINES (9.5%). These destinations reflect Bharat Serums AND Vaccines Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Folic from Bharat Serums AND Vaccines Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HIGEN COMPANY | IRAQ | $369.6K | 8 |
| TO CIMB ISLAMIC BANK | MALAYSIA | $123.9K | 3 |
| BSV BIOSCIENCE MALAYSIA SDN BHD | MALAYSIA | $111.1K | 6 |
| FIRST LINE PHARMACEUTICALS SDN BHD | MALAYSIA | $89.6K | 2 |
| FIRSTLINE PHARMACEUTICALS SDN | MALAYSIA | $76.8K | 2 |
| CHANRAI HEALTHCARE LTD, | NIGERIA | $54.6K | 2 |
| BSV BIOSCIENCE PHILIPPINES INC. | PHILIPPINES | $53.3K | 4 |
| FIRSTLINE PHARMACEUTICALS SDN BHD | MALAYSIA | $50.0K | 1 |
| TO CIMB ISLAMIC BANK BERHAD (671380 | MALAYSIA | $39.6K | 1 |
| BSV BIOSCIENCE PHILS INC | PHILIPPINES | $27.2K | 1 |
Bharat Serums AND Vaccines Limited supplies Folic to 30 buyers globally. The largest buyer is HIGEN COMPANY (IRAQ), followed by TO CIMB ISLAMIC BANK (MALAYSIA) and BSV BIOSCIENCE MALAYSIA SDN BHD (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Folic Export Value and How Much Does Bharat Serums AND Vaccines Limited Contribute?
India exported $22.4M worth of Folic through 5,361 shipments from 693 suppliers to 148 countries, serving 1,433 buyers globally. Bharat Serums AND Vaccines Limited contributes $1.3M to this total, accounting for 2.4% of India's Folic exports. Bharat Serums AND Vaccines Limited ships Folic to 11 countries through 30 buyers.
What Is the Average Shipment Value for Bharat Serums AND Vaccines Limited's Folic Exports?
Bharat Serums AND Vaccines Limited's average Folic shipment value is $17.1K per consignment, based on 78 shipments totaling $1.3M. The largest destination is MALAYSIA (41.3% of Bharat Serums AND Vaccines Limited's Folic exports).
How Does Bharat Serums AND Vaccines Limited Compare to Other Indian Folic Exporters?
Bharat Serums AND Vaccines Limited ranks #9 among 693 Indian Folic exporters with a 2.4% market share. The top 3 exporters are GRACURE PHARMACEUTICALS LIMITED ($3.0M), STRIDES PHARMA SCIENCE LIMITED ($2.8M), CADILA PHARMACEUTICALS LIMITED ($2.6M). Bharat Serums AND Vaccines Limited processed 78 shipments to 11 destination countries.
What Folic Formulations Does Bharat Serums AND Vaccines Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FOLICULIN 150 IU [UROFOLLITROPIN FOR INJ | $123.9K | 3 |
| FOLICULIN 75 IU HP [Urofollitropin for I | $119.6K | 3 |
| FOLICULIN 75 IU HP UROFOLLITROPIN FOR INJECTION B.P. FREEZE DRIED (HIGHLY PURIFIED) | $100.0K | 2 |
| FOLICULIN 75 IU [Urofollitropin for Inje | $82.0K | 3 |
| FOLICULIN 75 IU HP [UROFOLLITROPIN FOR I | $50.0K | 1 |
| FOLICULIN 150 IU UROFOLLITROPIN FOR INJE | $50.0K | 1 |
| FOLICULIN 150 IU [Urofollitropin for Inj | $50.0K | 1 |
| FOLICULIN 75 IU HP [Urofollitropin for Injection B.P.] [Freeze Dried Highly Purified | $50.0K | 1 |
| FOLICULIN 150 IU [UROFOLLITROPIN FOR INJECTION B.P.] - FREEZE DRIED | $50.0K | 1 |
| FOLICULIN 75 IU HP UROFOLLITROPIN FOR INJECTION B P FREEZE DRIED HIGHLY PURIFIED 25000 VLS | $50.0K | 1 |
Bharat Serums AND Vaccines Limited exports 51 distinct Folic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FOLICULIN 150 IU [UROFOLLITROPIN FOR INJ with 3 shipments worth $123.9K.
How Does Bharat Serums AND Vaccines Limited Compare to Nearest Folic Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MEDICAMEN BIOTECH LIMITED | $2.0M | 41 | 13 | $50.0K |
| 8 | MICRO LABS LIMITED | $1.6M | 79 | 12 | $20.0K |
| 9 | BHARAT SERUMS AND VACCINES LIMITED ★ | $1.3M | 78 | 11 | $17.1K |
| 1 | UMAVIDA PHARMA PRIVATE LIMITED | $1.1M | 23 | 1 | $50.0K |
| 11 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED | $1.0M | 23 | 5 | $45.5K |
Bharat Serums AND Vaccines Limited ranks #9 among 693 Indian Folic exporters. Average shipment value of $17.1K compared to the market average of $32.3K. The closest competitors by value are MEDICAMEN BIOTECH LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Folic Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 679 | 12.7% |
| JNPT | 390 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 348 | 6.5% |
| SAHAR AIR | 334 | 6.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 284 | 5.3% |
| MUNDRA SEA | 184 | 3.4% |
| DELHI AIR | 158 | 2.9% |
| PATLI ICD | 153 | 2.9% |
Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Folic Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like BSV. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter trade routes, resulting in extended transit times and increased freight rates on key India–Europe shipping lanes. These disruptions can impact the timely delivery of pharmaceutical products, potentially affecting supply chains and customer relationships. (livemint.com)
Conversely, the India–European Union Free Trade Agreement, concluded in January 2026, is poised to eliminate tariffs on Indian pharmaceutical exports to the EU. This development enhances the competitiveness of Indian exporters like BSV in the European market, potentially offsetting some of the logistical challenges posed by current shipping disruptions. (en.wikipedia.org)
Additionally, ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian manufacturers to increase their market share in the US. BSV's established presence in critical care and biologics positions it well to capitalize on this shift.
Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. BSV's adherence to stringent quality requirements, including FDA, WHO, and EU GMP standards, has been instrumental in maintaining its export credentials. The company's focus on high-entry-barrier products necessitates continuous investment in quality assurance and regulatory compliance to meet the evolving standards of global markets.
The recent acquisition by Mankind Pharma is expected to bolster BSV's compliance infrastructure, leveraging Mankind's resources to enhance quality systems and ensure sustained adherence to international regulatory expectations.
About Bharat Serums AND Vaccines Limited
Bharat Serums AND Vaccines Limited exports 4 products worth $40.1M. Beyond Folic, top products include Immunoglobulin, Amphotericin, Serum. View the complete Bharat Serums AND Vaccines Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Folic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Folic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Bharat Serums AND Vaccines Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 78 individual customs records matching Bharat Serums AND Vaccines Limited exporting Folic, covering 51 formulations to 11 countries via 30 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 1,433+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Folic Export Data from Bharat Serums AND Vaccines Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bharat Serums AND Vaccines Limited's Folic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bharat Serums AND Vaccines Limited
Full Company Profile →
4 products · $40.1M total trade · 3 categories
Folic Stats
Company Overview
Top Products by Bharat Serums AND Vaccines Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Bharat Serums AND Vaccines Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Folic. For current shipment-level data, contact TransData Nexus.